Form 8-K - Current report:
SEC Accession No. 0001193125-25-003574
Filing Date
2025-01-08
Accepted
2025-01-08 17:30:04
Documents
17
Period of Report
2025-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d861550d8k.htm   iXBRL 8-K 29076
2 EX-99.1 d861550dex991.htm EX-99.1 36444
7 GRAPHIC g861550g41t22.jpg GRAPHIC 33296
8 GRAPHIC g861550page2.jpg GRAPHIC 10677
  Complete submission text file 0001193125-25-003574.txt   296237

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20250108.xsd EX-101.SCH 3099
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20250108_def.xml EX-101.DEF 13865
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20250108_lab.xml EX-101.LAB 22896
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20250108_pre.xml EX-101.PRE 14703
19 EXTRACTED XBRL INSTANCE DOCUMENT d861550d8k_htm.xml XML 5887
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 25519431
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)